基于树突状细胞疫苗的胶质母细胞瘤免疫疗法的发展。
The development of dendritic cell vaccine-based immunotherapies for glioblastoma.
机构信息
Center for Neuro-Oncology, Dana-Farber Cancer Institute, 450 Brookline Ave, Dana 2134, Boston, MA, 02215-5450, USA.
Preston A. Wells, Jr. Center for Brain Tumor Therapy, Lillian S. Wells Department of Neurosurgery, McKnight Brain Institute, University of Florida, Gainesville, FL, 32605, USA.
出版信息
Semin Immunopathol. 2017 Feb;39(2):225-239. doi: 10.1007/s00281-016-0616-7. Epub 2017 Jan 30.
PMID:28138787
Abstract
In this review, we focus on the biologic advantages of dendritic cell-based vaccinations as a therapeutic strategy for cancer as well as preclinical and emerging clinical data associated with such approaches for glioblastoma patients.
摘要
在这篇综述中，我们专注于基于树突状细胞的疫苗接种作为癌症治疗策略的生物学优势，以及与胶质母细胞瘤患者的这种方法相关的临床前和新兴临床数据。
Zotero 插件